Physician profile
Imran Saeed
NPI 1669501748
$3,803.09
in general payments reported to CMS, 2019-2025
10 companies · $933 in 2025
The $933 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,031 · 2020: $13.08 · 2021: $57.57 · 2022: $137 · 2023: $1,608 · 2024: $23.70 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,269 · Food and Beverage: $779 · Education: $500 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,269.39 |
| Food and Beverage | $778.85 |
| Education | $500.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,414.61 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $894.43 | 2022-2025 | Altaviva, Progrip |
| Integra Lifesciences Corporation | $174.10 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $142.61 | 2025 | Arista |
| Ethicon US, LLC | $56.99 | 2025 | Echelon Flex |
| Braintree Laboratories, INC. | $47.19 | 2019 | |
| Shire North American Group INC | $23.98 | 2019 | |
| Daiichi Sankyo INC. | $23.07 | 2019 | |
| Boston Scientific Corporation | $13.08 | 2020 | |
| Allergan, INC. | $13.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.